Literature DB >> 21194823

Randomized clinical trial to assess the efficacy of a comprehensive programme of secondary prevention of cardiovascular disease in general practice: the PREseAP study.

Carlos Brotons1, Núria Soriano, Irene Moral, María P Rodrigo, Pilar Kloppe, Ana I Rodríguez, María L González, Dolores Ariño, Domingo Orozco, Francisco Buitrago, Josep M Pepió, Isabel Borrás.   

Abstract

INTRODUCTION AND
OBJECTIVES: To assess the efficacy of a comprehensive program of secondary prevention of cardiovascular disease in general practice.
METHODS: A cluster randomized clinical trial was carried out in a regular general practice setting. Male and female patients aged under 86 years with a diagnosis of ischemic heart disease, stroke or peripheral artery disease were recruited between January 2004 and May 2005. Study participants were seen at 42 health centers throughout the whole of Spain. The primary endpoint was the combination of all-cause mortality and hospital cardiovascular readmission at 3-year follow-up.
RESULTS: In total, 1224 patients were recruited: 624 in the intervention group and 600 in the control group. The primary endpoint was observed in 29.9% (95% confidence interval [CI], 25.5-34.8%) in the intervention group and 25.6% (22.3-29.2%) in the control group (P=.15). At the end of follow-up, 8.5% (6.3-11.3%) in the intervention group and 11% (7.4-16%) in the control group were smokers (P=.07). The mean waist circumference of patients in the intervention and control groups was 100.44 cm (95% CI, 98.97-101.91 cm) and 102.58 cm (95% CI, 100.96-104.21 cm), respectively (P=.07). Overall, 20.9% (15.6-27.7%) of patients in the intervention group and 29.6% (23.9-36.1%) in the control group suffered from anxiety (P=.05), and 29.6% (22.4-37.9%) in the intervention group and 41.4% (35.8-47.3%) in the control group had depression (P=.02).
CONCLUSIONS: A comprehensive program of secondary prevention of cardiovascular disease in general practice was not effective in reducing cardiovascular morbidity and mortality. However, some factors associated with a healthy lifestyle were improved and anxiety and depression were reduced.
Copyright © 2010 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21194823     DOI: 10.1016/j.recesp.2010.07.005

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  12 in total

Review 1.  Information provision for stroke survivors and their carers.

Authors:  Thomas F Crocker; Lesley Brown; Natalie Lam; Faye Wray; Peter Knapp; Anne Forster
Journal:  Cochrane Database Syst Rev       Date:  2021-11-23

2.  Secondary prevention: the ongoing challenge.

Authors:  Véronique L Roger
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2010-12-18

Review 3.  Association between anxiety and mortality in patients with coronary artery disease: A meta-analysis.

Authors:  Christopher M Celano; Rachel A Millstein; C Andres Bedoya; Brian C Healy; Annelieke M Roest; Jeff C Huffman
Journal:  Am Heart J       Date:  2015-09-21       Impact factor: 4.749

Review 4.  Interventions for improving modifiable risk factor control in the secondary prevention of stroke.

Authors:  Bernadeta Bridgwood; Kate E Lager; Amit K Mistri; Kamlesh Khunti; Andrew D Wilson; Priya Modi
Journal:  Cochrane Database Syst Rev       Date:  2018-05-07

5.  Nurse-Led, Telephone-Based, Secondary Preventive Follow-Up after Stroke or Transient Ischemic Attack Improves Blood Pressure and LDL Cholesterol: Results from the First 12 Months of the Randomized, Controlled NAILED Stroke Risk Factor Trial.

Authors:  Anna-Lotta Irewall; Joachim Ögren; Lisa Bergström; Katarina Laurell; Lars Söderström; Thomas Mooe
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

Review 6.  Exercise for intermittent claudication.

Authors:  Risha Lane; Amy Harwood; Lorna Watson; Gillian C Leng
Journal:  Cochrane Database Syst Rev       Date:  2017-12-26

Review 7.  Information provision for stroke patients and their caregivers.

Authors:  Anne Forster; Lesley Brown; Jane Smith; Allan House; Peter Knapp; John J Wright; John Young
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

8.  Effectiveness of a new health care organization model in primary care for chronic cardiovascular disease patients based on a multifactorial intervention: the PROPRESE randomized controlled trial.

Authors:  Domingo Orozco-Beltran; Esther Ruescas-Escolano; Ana Isabel Navarro-Palazón; Alberto Cordero; María Gaubert-Tortosa; Jorge Navarro-Perez; Concepción Carratalá-Munuera; Salvador Pertusa-Martínez; Enrique Soler-Bahilo; Francisco Brotons-Muntó; Jose Bort-Cubero; Miguel Angel Nuñez-Martinez; Vicente Bertomeu-Martinez; Vicente Francisco Gil-Guillen
Journal:  BMC Health Serv Res       Date:  2013-08-02       Impact factor: 2.655

9.  Long-term, telephone-based follow-up after stroke and TIA improves risk factors: 36-month results from the randomized controlled NAILED stroke risk factor trial.

Authors:  Joachim Ögren; Anna-Lotta Irewall; Lars Söderström; Thomas Mooe
Journal:  BMC Neurol       Date:  2018-09-21       Impact factor: 2.474

10.  Adherence to European Clinical Practice Guidelines for Secondary Prevention of Cardiovascular Disease: A Cohort Study.

Authors:  Josep Maria Pepió Vilaubí; Domingo Orozco-Beltrán; Alessandra Queiroga Gonçalves; Dolors Rodriguez Cumplido; Carina Aguilar Martin; Adriana Lopez-Pineda; Vicente F Gil-Guillen; Jose A Quesada; Concepcion Carratala-Munuera
Journal:  Int J Environ Res Public Health       Date:  2018-06-11       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.